Viking Therapeutics Inc (VKTX · NASDAQ)
VKTX · MARKET VIEW
Market view · as of Aug 31, 2026
Revenue (TTM)
$0
0.0% YoY
EPS (latest q)
$-1.10
vs $-1.21 est · beat
52-wk position
47.6%
-23.7% vs 52w high · +1.3% 1mo
Price (last ~year)
Viking Therapeutics, a clinical-stage biopharmaceutical company focused on metabolic disorders, reported no revenue for the trailing twelve months and a $132.6 million operating loss for the quarter ending June 30, 2026. The company holds $125.8 million in cash against $4.1 million in total debt as it advances late-stage trials for its obesity drug candidate, VK2735. Shares closed at $32.16, down 5.0% over the last trading day, with a market capitalization of $3.75 billion.
Valuation
- Market cap
- $3.75B
- PEG
- -0.03
- P/B
- 9.67
- EV/EBITDA
- -71.64
- Beta
- 0.685
- Analyst target
- $92.39
Quality & returns
- Operating margin
- 0.0%
- Profit margin
- 0.0%
- ROE
- -88.8%
- ROA
- -51.9%
Price movement
- Last
- $32.16
- 1-month
- +1.3%
- 3-month
- +9.6%
- RSI (14)
- 40
- vs SMA200
- -4.4%
- 52-wk position
- 47.6% -23.7% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-06-30 | $0 | $-132.6M | $-128.0M | $-127.9M |
| 2026-03-31 | $0 | $-164.1M | $-158.3M | $-158.3M |
| 2025-12-31 | $0 | $-164.7M | $-157.7M | $-157.6M |
| 2025-09-30 | $0 | $-98.6M | $-90.8M | $-90.7M |
Recent news
- Somewhat-Bearish Viking Therapeutics Inc (XTER:1VT) Stock Price, Trades & News · 2026-08-24
- Neutral Viking Therapeutics Inc (XTER:1VT) Stock Earnings Transcripts · 2026-08-24
- Neutral Viking Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference Transcript · 2026-08-24
- Neutral VKTX Stock Steady After-Hours On Positive Obesity Drug Pipeline Progress · 2026-08-21
- Neutral Viking Therapeutics (NASDAQ:VKTX) Upgraded to Hold at Zacks Research · 2026-08-20
- Neutral Viking Therapeutics (VKTX) Stock Still Looks Pricey With Pipeline Hopes Priced In · 2026-08-19
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)